Ipsen Plunges as FDA Halts Bone Drug Trial in Children on Safety Concerns

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 6, 2019 at 9:52 AM.

  1. #1 cafead, Dec 6, 2019 at 9:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via French drugmaker Ipsen SA had a record plunge after U.S. regulators suspended trials of its experimental treatment for rare bone diseases in patients under 14 on safety concerns.

    article source
     
    Quote

Reply to Thread